BRD4 and acute myeloid leukemia: NSD3 is involved in several varieties of cancers as it contributes to tumorigenesis by interacting with the bromodomain-containing protein 4 (BRD4) and the bromodomain and extra-terminal (BET) protein, which are potential therapeutic targets in acute myeloid leukemia (Han et al., 2018).